Postoperative calcitonin study in medullary thyroid carcinoma.
Authors:
Open Access
- 1 June 2004
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 11 (2) , 357-363
Abstract
Calcitonin (CT) is a sensitive marker for medullary thyroid carcinoma. Normalization of early postoperative CT level is a favorable prognostic factor. The aim of this study was to establish the prognostic value of CT-level kinetics by preoperative tumor stage and postoperative elimination rate. Blood serum from 22 medullary thyroid carcinoma (MTC) patients without remote metastases was assayed. A commercial RIA DSL-1200 test was used to assay CT levels. Basal CT< or =42 pg/ml and stimulated CT< or =120 pg/ml were considered normal. The patients were divided into three groups according to the intensity of the postoperative CT level reduction in blood serum. Group 1 comprised patients who showed basal CT normalization within the first 2-3 days after surgery. Group 2 included those patients with slow (from 2 to 4 weeks) CT-level normalization. Group 3 included patients with CT levels that reduced within 14 days, but subsequently increased. Preoperative basal CT varies from 216 to 1654 pg/ml and depends on tumor-node-metastasis (TNM) stage. In seven patients, no basal CT decrease to normal values was observed; in five of these patients, disease recurrence was detected 2-6 months after surgery. In the group with slowly decreasing CT levels, no strong correlation between preoperative CT level and the postoperative time to normalization of basal and peak CT could be established; this may be due to the small number of patients. Our study showed that preoperative CT level depended on the disease stage. Postoperative CT elimination rate is independent of preoperative CT level. Postoperative increase in the basal or stimulated CT level is an unfavorable prognostic factor, implying disease recurrence.Keywords
This publication has 16 references indexed in Scilit:
- Calcitonin kinetics in the early postoperative period of medullary thyroid carcinomaLangenbeck's Archives of Surgery, 2001
- Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene—related peptideMetabolism, 2000
- Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid CarcinomaWorld Journal of Surgery, 1998
- Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levelsSurgery, 1996
- Disappearance Rate of Serum Calcitonin after Total Thyroidectomy for Medullary Thyroid CarcinomaThe International Journal of Biological Markers, 1994
- Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.The Journal of Clinical Endocrinology & Metabolism, 1994
- Expression and Function of the Calcitonin Gene Products1991
- Diagnosis of Medullary Carcinoma of the Thyroid (MCT) by Calcitonin Assay Using Monoclonal Antibodies: Criteria for the Pentagastrin Stimulation Test in Hereditary MCTThe Journal of Clinical Endocrinology & Metabolism, 1990
- Relation of Doubling Time of Plasma Calcitonin Levels to Prognosis and Recurrence of Medullary Thyroid CarcinomaAnnals of Surgery, 1984
- The Early Diagnosis of Medullary Carcinoma of the Thyroid Gland in Patients with Multiple Endocrine Neoplasia Type IIAnnals of Surgery, 1975